Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to alleviate symptoms and slow the progression of the underlying neurodegenerative process, even though a cure remains elusive.

Parkinsonism is a clinical syndrome involving bradykinesia, muscular rigidity, resting tremor, and impaired postural balance. The most predominant Parkinsonism is idiopathic Parkinson's disease, featuring degeneration of dopaminergic neurons in the substantia nigra region of the brain. Pseudoparkinsonism, on the other hand, mimics the symptoms of Parkinson's but is usually caused by certain dopamine-disrupting medications like haloperidol and phenothiazine or other health conditions. The pathophysiology of Parkinson's disease involves basal ganglia dysfunction and an imbalance between direct and indirect neural pathways. This disease's primary pathological feature includes Lewy bodies and intracellular inclusions containing aggregated α-synuclein proteins.

Treatment for Parkinsonism primarily uses levodopa (L-DOPA), a dopamine precursor that increases its levels in the brain, helping to manage the symptoms. It may be used in conjunction with carbidopa (Lodosyn). Ongoing research focuses on developing newer and better therapeutic strategies, such as immunization against α-synuclein and gene therapy. Despite the challenges, understanding the mechanisms behind these disorders offers hope for future breakthroughs in their management and potential cure.

Z rozdziału 15:

article

Now Playing

15.5 : Parkinson's Disease: Overview

Pharmacotherapy of Depression and Anxiety Disorders

113 Wyświetleń

article

15.1 : Depresja: Przegląd

Pharmacotherapy of Depression and Anxiety Disorders

114 Wyświetleń

article

15.2 : Leki przeciwdepresyjne: przegląd

Pharmacotherapy of Depression and Anxiety Disorders

191 Wyświetleń

article

15.3 : Leki przeciwdepresyjne: trójpierścieniowe, SSRI i SNRI

Pharmacotherapy of Depression and Anxiety Disorders

119 Wyświetleń

article

15.4 : Leki przeciwdepresyjne: MAO i inne środki

Pharmacotherapy of Depression and Anxiety Disorders

83 Wyświetleń

article

15.6 : Choroba Parkinsona: leczenie

Pharmacotherapy of Depression and Anxiety Disorders

78 Wyświetleń

article

15.7 : Choroba Alzheimera: przegląd

Pharmacotherapy of Depression and Anxiety Disorders

147 Wyświetleń

article

15.8 : Choroba Alzheimera: leczenie

Pharmacotherapy of Depression and Anxiety Disorders

77 Wyświetleń

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone